2000
DOI: 10.1152/ajpregu.2000.279.1.r47
|View full text |Cite
|
Sign up to set email alerts
|

Long-term orexigenic effects of AgRP-(83—132) involve mechanisms other than melanocortin receptor blockade

Abstract: Overexpression of agouti-related peptide (AgRP), an endogenous melanocortin (MC) 3 and 4 receptor antagonist (MC3/4-R), causes obesity. Exogenous AgRP-(83---132) increases food intake, but its duration and mode of action are unknown. We report herein that doses as low as 10 pmol can have a potent effect on food intake of rats over a 24-h period after intracerebroventricular injection. Additionally, a single third ventricular dose as low as 100 pmol in rats produces a robust increase in food intake that persist… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

15
172
0
3

Year Published

2002
2002
2012
2012

Publication Types

Select...
5
5

Relationship

0
10

Authors

Journals

citations
Cited by 258 publications
(192 citation statements)
references
References 46 publications
15
172
0
3
Order By: Relevance
“…However, there may also be significant differences in the mechanisms by which PG932 and other antagonists affect homeostasis. For example, it is known that central administration of a single picomole dose of AgRP, and SHU9119, increase food intake for up to seven days, possibly due to long term alterations in the activity of neurons involved in reward and satiety [16,17]. AgRP is also an inverse agonist at the Mc4r, and it not known whether PG932 has inverse agonist activity [18,31].…”
Section: Discussionmentioning
confidence: 99%
“…However, there may also be significant differences in the mechanisms by which PG932 and other antagonists affect homeostasis. For example, it is known that central administration of a single picomole dose of AgRP, and SHU9119, increase food intake for up to seven days, possibly due to long term alterations in the activity of neurons involved in reward and satiety [16,17]. AgRP is also an inverse agonist at the Mc4r, and it not known whether PG932 has inverse agonist activity [18,31].…”
Section: Discussionmentioning
confidence: 99%
“…AgRP gene expression increases with food deprivation in the arcuate nucleus of laboratory rats and of Siberian hamsters (Hahn et al 1998;Mercer et al 2000) as noted above. In addition, third ventricular, PVH or dorsomedial hypothalamic nucleus injections of AgRP in rats profoundly stimulates food intake, doing so for several days (Hagan et al 2000;Kim et al 2000;Wirth & Giraudo 2000). Previous studies also indicate that the ghrelin-induced increases in food intake in rats are mediated by the melanocortin 3 and 4 receptors (MC-3/4Rs; Kamegai et al 2000Kamegai et al , 2001Nakazato et al 2001).…”
Section: Central Factorsmentioning
confidence: 99%
“…Consistent with this perspective: (i) leptin receptors are expressed on arcuate hypothalamic neurons that also express POMC or AgRP, (ii) leptin treatment increases expression of POMC mRNA and decreases AgRP mRNA, and (iii) the synthetic melanocortin 3/4 receptor (MC3/4-R) antagonist, SHU-9119, reverses the short-term intake inhibition that follows icv application of leptin (123,164,201). Direct agonist stimulation of MC3/4-R via icv treatment produces a short-latency, dose-related inhibition of food intake that lasts for 24 h, while antagonist treatment yields a robust hyperphagia that persists for several days after a single application (70,83).…”
Section: Melancortinmentioning
confidence: 99%